Table 1:

Baseline characteristics stratified by insurance.

	Underinsured (n=20)	Insured (n=11)	p-Value	OR	95% Lower CI	95% Upper CI
Age, years	57 (36–76)	60 (46–74)	0.43
Female gender	15 (75%)	10 (91%)	0.28	0.30	0.03	2.97
Race
White vs Non-white	7 (35%)	7 (64%)	0.13	0.31	0.07	1.43
Pathology
Primary (Appendix, Primary peritoneal, Mesothelioma)	10 (50%)	2 (18%)	0.08	4.5	0.77	26.29
GI	8 (40%)	4 (36%)	0.84	1.17	0.26	5.33
GYN	2 (10%)	5 (45%)	0.02	0.13	0.02	0.88
Signet ring	1 (5%)	4 (36%)	0.02	0.09	0.01	0.97
EBL, mL	801 (10–2500)	814 (50–3000)	0.96
OR time, minutes	548 (183–828)	497 (131–840)	0.49
DM	3 (15%)	4 (36%)	0.17	0.31	0.05	1.75
HTN	7 (35%)	4 (36%)	0.94	0.94	0.20	4.37
Smoker	10 (50%)	5 (45%)	0.26	1.2	0.27	5.25
PCI	18.2 (2–33)	16.6 (2–32)	0.67
CC
0	16 (80%)	9 (82%)	0.90	0.89	0.14	5.85
1	3 (15%)	2 (18%)	0.82	0.79	0.11	5.66
2	1 (5%)	0 (0%)	1	1.77	0.07	47.14
Mean ICU length of stay (days)	24 (0–60)	9 (0–35)	0.41
Mean hospital length of stay (days)	18.5 (4–78)	18.7 (6–41)	0.96
Early complication	13 (65%)	5 (45%)	0.29	2.23	0.50	10
Late complication	8 (40%)	2 (18%)	0.21	3	0.51	17.69
Morbidity – Clavien–Dindo	16 (80%)	8 (64%)	0.64	1.50	0.27	8.38
I-II	6	2	0.47	1.93	0.32	11.74
III-IV	9	5	0.98	0.98	0.22	4.3
Mortality 30 day	0 (0%)	0 (0%)	1	0.56	0.01	30.2
Mortality 90 day	1 (5%)	1 (9%)	1	0.53	0.03	9.33
Survival days (Mean)	1173 (97–2335)	978 (103–1642)	0.38

EBL, estimated blood loss.